David Goldblatt is Professor of Vaccinology and Immunology at the Great Ormond Street Institute of Child Health, University College London (UCL) and a Paediatric Immunologist at the Great Ormond Street Hospital for Children where he is Director of Research and Development. He obtained his medical degree from the University of Cape Town, South Africa, and a PhD in Immunology from the University of London, UK. He has a long-standing interest in the immune response to vaccines, infectious diseases and correlates of protection. His major focus on the Pneumococcus has recently expanded to evaluating immunity to bacterial candidate vaccines including Group A and Group B Streptococcus and Klebsiella Pneumoniae. He recently established a platform for evaluating humoral immunity to SARS-CoV-2 with focus on developing correlates of protection to accelerate COVID19 vaccine licensure. He is a regular advisor to the World Health Organisation (WHO) on vaccines and is Director of the WHO Reference Laboratory for Pneumococcal Serology based at UCL. He serves on subcommittees of the United Kingdom Department of Health Joint Committee on Vaccines and Immunisation (JCVI) has advised the US FDA, EMA and MHRA on vaccine evaluation and the currently sits on COVID vaccine committees for MHRA and WHO.